Arthur Taveras's Insider Trades & SAST Disclosures

Arthur Taveras's most recent trade in X4 Pharmaceuticals Inc was a trade of 230,645 Common Stock done . Disclosure was reported to the exchange on Oct. 4, 2024.

Stock Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
X4 Pharmaceuticals Inc
Arthur Taveras Chief Scientific Officer 04 Oct 2024 230,645 464,946 (2%) 1% 0 Common Stock
X4 Pharmaceuticals Inc
Arthur Taveras Chief Scientific Officer 04 Oct 2024 76,920 388,026 (2%) 0% 0.6 43,306 Common Stock
X4 Pharmaceuticals Inc
Arthur Taveras Chief Scientific Officer 11 Mar 2024 14,235 234,301 (1%) 0% 0.9 12,552 Common Stock
X4 Pharmaceuticals Inc
Taveras Arthur Chief Scientific Officer 13 Feb 2024 428,248 428,248 - - Stock Appreciation Right
X4 Pharmaceuticals Inc
Arthur Taveras Chief Scientific Officer 12 Feb 2024 787 248,536 (1%) 0% 1.0 793 Common Stock
X4 Pharmaceuticals Inc
Arthur Taveras Chief Scientific Officer 10 Mar 2023 16,806 86,373 (0%) 0% 0.8 14,117 Common Stock
X4 Pharmaceuticals Inc
Arthur Taveras Chief Scientific Officer 13 Feb 2023 928 103,179 (0%) 0% 0.9 863 Common Stock
X4 Pharmaceuticals Inc
Arthur Taveras Chief Scientific Officer 07 Nov 2022 1,000,000 1,000,000 - - Stock Appreciation Right
X4 Pharmaceuticals Inc
Arthur Taveras Chief Scientific Officer 01 Mar 2022 97,000 104,107 (0%) 0% 0 Common Stock
X4 Pharmaceuticals Inc
Arthur Taveras Chief Scientific Officer 11 Feb 2022 928 7,107 (0%) 0% 0 Common Stock
X4 Pharmaceuticals Inc
Arthur Taveras Chief Scientific Officer 24 Mar 2021 8,035 8,035 (0%) 0% 0 Common Stock
X4 Pharmaceuticals Inc
Arthur Taveras Chief Scientific Officer 30 Nov 2020 121,150 121,150 - - Stock Option (right to buy)
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades